Arjuna Natural will highlight ashwagandha extract for cognition support at Vitafoods Europe 2025
The effects of Somin-On for cognition support in older adults were assessed in a recently published study.
Image | adobe.stock/Alexandra
In an April 23, 2025, press release, Arjuna Natural announced it would showcase its ashwagandha extract at Vitafoods Europe 2025, highlighting recent research demonstrating its potential for supporting memory in adults with mild cognitive impairment (MCI). The extract, Somin-On, is standardized to a 2% content Sominone and is formulated to support multiple cognitive functions. Somin-On was developed as a sequel to Shoden, Arjuna’s original ashwaghanda extract, which was designed for stress relief and sleep support.
“Our new ashwagandha formulation was developed in direct response to the rising concerns of cognitive decline among today’s aging population,” stated Benny Antony, PhD, joint managing director of Arjuna Natural, in the press release. “This group is actively seeking natural solutions to maintain mental clarity and focus, and help prevent any potential onset of dementia as its members age. Somin-On offers a promising, safe and natural approach for supporting brain function helping older adults stay sharp and mentally agile.”
In a randomized double-blind, placebo-controlled pilot study1 published in March 2025, 40 participants were given either Somin-On (250 mg daily) or a placebo, with cognitive assessments performed at 30 and 60 days after the start of the trial.
Highlighted results from the study include:
- Using the Wechsler Memory Scale-III (WMS-III), participants taking Somin-On demonstrated significant improvement in immediate memory, general memory, working memory and visuospatial processing and the response compared with the placebo group
- The Somin-On group demonstrated a 12.22% rise in scores on the Shepard Mental Rotation test for visuospatial processing at 30 days and 31.67% at 60 days
- With the Montreal Cognitive Assessment (MoCA) assessing memory, the Somin-On group demonstrated a 7.83% improvement at 30 days and 14.77% at 60 days
- The Somin-On group also demonstrated a 9.26% improvement at 30 days and 19.21% at 60 days with the Mini–mental state examination (MMSE), a significant improvement compared with placebo.
“Sominone, derived from Withania somnifera, is identified as the main active metabolite responsible for these specific effects,” explained Antony. “Ashwagandha is a traditional Ayurvedic herb that has been widely used for centuries to manage stress and anxiety, and cognitive support function. This compound has been identified and extensively analyzed for its potential benefits in enhancing memory and cognitive functions.”
Arjuna will be at Booth 4J2 at Vitafoods Europe, taking place May 20-22 in Barcelona, Spain.
Reference
- Rai HP.; Mishra DN. Effect of ashwagandha (Withania somnifera) extract with Sominone (Somin-OnTM;) to improve memory in adults with mild cognitive impairment: A randomized, double-blind, placebo-controlled study. Journal of Psychopharmacology. 2025. DOI: 10.1177/02698811251324377.
